Meeting
2021 ASCO Annual Meeting
Comprehensive genomic profiling (CGP) of 275 male breast cancer (BC) tissue (TBx) and liquid (LBx) biopsies: Comparative analysis to a female cohort (FBC) and therapeutic considerations.
Authors
Arun Kadamkulam Syriac
Dana Farber Cancer Institute/St. Elizabeth Hospital, Boston, MA
Arun Kadamkulam Syriac , Allison Clark , Mehrad Tavallai , Dexter X. Jin , Ethan Sokol , Kimberly McGregor , Jeffrey S. Ross , Natalie Danziger , Jose Pablo Leone
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 539)
DOI
10.1200/JCO.2021.39.15_suppl.539
Abstract #
539
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Patient-matched tissue and liquid biopsies identify shared and acquired genomic alterations in breast cancer.
First Author: Ethan Sokol
Poster
2020 ASCO Virtual Scientific Program
Genomic profiling of breast cancer brain metastases reveals targetable alterations.
First Author: Sheheryar Kairas Kabraji
Poster
2017 Genitourinary Cancers Symposium
Circulating tumor (ct)-DNA alterations in advanced urothelial carcinoma: Association with outcomes and evolution with therapy.
First Author: Petros Grivas
Poster
2022 ASCO Annual Meeting
DOLAF: An international multicenter phase II trial of durvalumab (MEDI4736) plus olaparib plus fulvestrant in patients with metastatic or locally advanced ER-positive, HER2-negative breast cancer selected using criteria that predict sensitivity to olaparib.
First Author: Severine Guiu Lahaye